Pick Today's Price Range Low-High... Just for Fun, page-604

ps I believe in company, i am getting tired of the loose language


Aren't we all ..... I do find it amusing that the people cheering about the BLA announcement on Monday stating it's only a week or two delay are failing to grasp what it is that some of us are actually annoyed about ? I don't have an issue with the delay itself to get the BLA sorted and it hasn't changed my investment strategy in Mesoblast but it's as you say @Kerebrad the loose language on multiple occasions by the CEO in the public domain that ends up falling short that is becoming a real issue in relation to market confidence having been here so many times before


Sadly the BLA delay isn't the only thing the CEO has been publicly grandstanding that hasn't come to fruition ..... take the CLBP trial rhetoric since the December quarterly and subsequent Webinar detailed in Post #:72703732 . Mesoblast / SI stated that the "The pivotal trial is now underway across multiple sites. With the CRO engaged to recruit patients across the US."


Subsequent to this Webinar the CEO has stated on more than one occasion publicly that the first patient would be dosed in the June quarter .....as we know from public records, not one patient has been 'dosed' in the CLBP trial almost 6 months after it was supposedly 'underway' ?


Cheer all you like people ... the market is showing us exactly what it thinks of the missed timelines and CEO grandstanding comments that have failed to materialise yet again and / or that Monday's BLA announcement isn't as 'positive' as some of you claimed..... and don't even get me started on the 'partnership' rhetoric that is dangled to shareholders constantly with absolutely nothing being signed ?


GLTAH


https://clinicaltrials.gov/study/NCT06325566?intr=Rexlemestrocel-L&rank=3